These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28110421)

  • 41. Understanding the CD8 T-cell response in natural HIV control.
    Boppana S; Goepfert P
    F1000Res; 2018; 7():. PubMed ID: 30026916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunobiology of dendritic cells and the influence of HIV infection.
    Cunningham AL; Harman A; Kim M; Nasr N; Lai J
    Adv Exp Med Biol; 2013; 762():1-44. PubMed ID: 22975870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells.
    Garg R; Trudel N; Tremblay MJ
    Trends Parasitol; 2007 Jul; 23(7):317-24. PubMed ID: 17531536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers.
    Martin-Gayo E; Cole MB; Kolb KE; Ouyang Z; Cronin J; Kazer SW; Ordovas-Montanes J; Lichterfeld M; Walker BD; Yosef N; Shalek AK; Yu XG
    Genome Biol; 2018 Jan; 19(1):10. PubMed ID: 29378643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-15-dependent immune crosstalk between natural killer cells and dendritic cells in HIV-1 elite controllers.
    Hartana CA; Lancien M; Gao C; Rassadkina Y; Lichterfeld M; Yu XG
    Cell Rep; 2023 Dec; 42(12):113530. PubMed ID: 38048223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic cell dysfunction during primary HIV-1 infection.
    Huang J; Yang Y; Al-Mozaini M; Burke PS; Beamon J; Carrington MF; Seiss K; Rychert J; Rosenberg ES; Lichterfeld M; Yu XG
    J Infect Dis; 2011 Nov; 204(10):1557-62. PubMed ID: 21969335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection.
    Lichterfeld M; Yu XG
    J Leukoc Biol; 2012 Jan; 91(1):27-33. PubMed ID: 22028331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myeloid dendritic cells in HIV-1 infection.
    Derby N; Martinelli E; Robbiani M
    Curr Opin HIV AIDS; 2011 Sep; 6(5):379-84. PubMed ID: 21743323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Innate Immune Response Against HIV-1.
    Murugaiah V; Yasmin H; Pandit H; Ganguly K; Subedi R; Al-Mozaini M; Madan T; Kishore U
    Adv Exp Med Biol; 2021; 1313():23-58. PubMed ID: 34661890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Keeping your armour intact: how HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS.
    Maelfait J; Seiradake E; Rehwinkel J
    Bioessays; 2014 Jul; 36(7):649-57. PubMed ID: 24782340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers.
    Hartana CA; Rassadkina Y; Gao C; Martin-Gayo E; Walker BD; Lichterfeld M; Yu XG
    J Clin Invest; 2021 May; 131(9):. PubMed ID: 33938445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The innate immune response to HIV-1: to sense or not to sense.
    Landau NR
    DNA Cell Biol; 2014 May; 33(5):271-4. PubMed ID: 24665823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue-like environments shape functional interactions of HIV-1 with immature dendritic cells.
    Gallucci L; Abele T; Fronza R; Stolp B; Laketa V; Sid Ahmed S; Flemming A; Müller B; Göpfrich K; Fackler OT
    EMBO Rep; 2023 Jun; 24(6):e56818. PubMed ID: 37042686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innate immune responses in primary HIV-1 infection.
    Borrow P; Bhardwaj N
    Curr Opin HIV AIDS; 2008 Jan; 3(1):36-44. PubMed ID: 19372942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of the innate immune system in controlling HIV infection and disease.
    Levy JA
    Trends Immunol; 2001 Jun; 22(6):312-6. PubMed ID: 11377290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Dendritic Cells in Viral Brain Infections.
    Constant O; Maarifi G; Blanchet FP; Van de Perre P; Simonin Y; Salinas S
    Front Immunol; 2022; 13():862053. PubMed ID: 35529884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function.
    Lee JH; Choi SY; Jung NC; Song JY; Seo HG; Lee HS; Lim DS
    J Cancer; 2020; 11(4):769-775. PubMed ID: 31949478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editorial: Innate immune responses in HIV controllers.
    Thobakgale C; Jost S
    Front Immunol; 2023; 14():1159278. PubMed ID: 36875132
    [No Abstract]   [Full Text] [Related]  

  • 59. The HIV capsid determines innate immune sensing of the viral cDNA in dendritic cells.
    Lahaye X; Manel N
    Virologie (Montrouge); 2014 Feb; 18(1):50-51. PubMed ID: 32260042
    [No Abstract]   [Full Text] [Related]  

  • 60. Editorial: Immune-mediated control of HIV.
    Bar KJ; Søgaard OS
    Curr Opin HIV AIDS; 2021 Sep; 16(5):241-242. PubMed ID: 34334613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.